INTEGRA LIFESCIENCES HOLDINGS CORP (IART) revenue & profit
INTEGRA LIFESCIENCES HOLDINGS CORP (IART): revenue $1.6B, net income -$516.8M in 2025; latest quarter +0.8% year over year. From SEC filings.
$1.6BRevenue 2025
TickerIART (Nasdaq)
IndustryHealthcare · Surgical & Medical Instruments & Apparatus
Revenue 2025$1.6B
Net income 2025-$516.8M
Net margin-31.6%
Annual revenue growth+1.5%
Latest quarter (2026 Q2) · Revenue$418.8M
vs. same quarter last year+0.8%
Latest quarter · Net income$4.5M
Annual revenue & net income
| Year | Revenue | Net income | |
|---|---|---|---|
| 2022 | $1.6B | $180.6M | |
| 2023 | $1.5B | $67.7M | |
| 2024 | $1.6B | -$6.9M | |
| 2025 | $1.6B | -$516.8M |
ℹ️ Not investment advice. Calendar-year figures as tagged by the SEC; a company’s fiscal year may end in a different month.